News
-
How Does Retatrutide Work? How Long Does It Take to See Results?
Retatrutide is a cutting-edge investigational drug that represents a new generation of weight management and metabolic therapies. Unlike traditional medications that target a single pathway, Retatr...Read more -
How Semaglutide Helps You Lose Weight？
Semaglutide is not just a weight-loss drug—it is a breakthrough therapy that targets the biological root causes of obesity. 1. Acts on the Brain to Suppress Appetite Semaglutide mimics the natural ...Read more -
Tirzepatide for Weight Reduction in Obese Adults
Background Incretin-based therapies have long been known to improve both blood glucose control and body weight reduction. Traditional incretin drugs primarily target the G...Read more -
What is the function of CJC-1295?
CJC-1295 is a synthetic peptide that functions as a growth hormone–releasing hormone (GHRH) analog — meaning it stimulates the body’s natural release of growth hormone (GH...Read more -
GLP-1–Based Therapies for Weight Loss: Mechanisms, Efficacy, and Research Advances
1. Mechanism of Action Glucagon-like peptide-1 (GLP-1) is an incretin hormone secreted by intestinal L-cells in response to food intake. GLP-1 receptor agonists (GLP-1 RAs) mimic this hormone’s phy...Read more -
GHRP-6 Peptide – Natural Growth Hormone Booster for Muscle and Performance
1. Overview GHRP-6 (Growth Hormone Releasing Peptide-6) is a synthetic peptide that stimulates the natural secretion of growth hormone (GH). Originally developed to treat GH deficiency, it has beco...Read more -
Tirzepatide Injection for Diabetes and Weight Loss
Tirzepatide is a novel dual glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptor agonist developed. Its dual mechanism aims to enhance insulin secretion, ...Read more -
What is PT-141?
Indication (approved use): In 2019, the FDA approved it for the treatment of acquired, generalized hypoactive sexual desire disorder (HSDD) in premenopausal women when the condition causes marked d...Read more -
Phase 2 Clinical Trial of Retatrutide, a Triple Hormone-Receptor Agonist, for the Treatment of Obesity
Background and Study Design Retatrutide (LY3437943) is a novel single-peptide drug that activates three receptors simultaneously: GIP, GLP-1, and glucagon. To evaluate its efficacy and safety in in...Read more -
What is BPC-157
Full name: Body Protection Compound-157, a pentadecapeptide (15-amino acid peptide) originally isolated from human gastric juice. Amino acid sequence: Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-As...Read more -
Higher doses of semaglutide can safely improve weight loss for adults living with obesity, clinical trials confirm
Clinical trials have confirmed that higher doses of Semaglutide can safely and effectively help adults with obesity achieve significant weight reduction. This finding offers a new therapeutic appro...Read more -
Retatrutide, a triple hormone receptor agonist, for the treatment of obesity – a phase II clinical trial
In recent years, the treatment of obesity and type 2 diabetes has undergone revolutionary progress. Following GLP-1 receptor agonists (e.g., Semaglutide) and dual agonists (e.g., Tirzepatide), Reta...Read more